HIV Mutation Detail Information

> S147G Search Result


Mutation Information
Mutation Site S147G
Mutation Type Amino acid level
Gene/Protein/Region Type IN
Relevant Drug bictegravir (BIC);emtricitabine (FTC);tenofovir alafenamide (TAF);dolutegravir (DTG)
Literature Information
PubMed PMID 32701823
Disease HIV infection/AIDS
Published Year 2020
Journal Journal of acquired immune deficiency syndromes (1999)
Title Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance.
Author Acosta RK,Willkom M,Andreatta K,Liu H,Martin R,Parvangada A,Martin H,Collins S,White KL
Evidence The most frequent substitution was T97A in 12 participants, followed by Y143H, N155H/S, and R263K in 2 participants each, and S147G in 1 participant.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation